New Pre-Thanksgiving Plays

SCHW, NDAQ, GS Plus AGN PCU, PVX & SUN

By Bryan Bottarelli
Monday, November 20, 2006 10:17 AM EST
Mon, 20 Nov 2006 15:17:00 GMT

Dear Bottarelli Research Member,

As you continue to monitor the upside moves on our PCU January 52.5 Calls (PCU AX), I’d like you to make sure that you lock in your gains on today’s upside action. If that means taking a price of $3.30 or $3.50, then go ahead and lock in the gains. With the recent volatility in the metals sector, I don’t want to risk our profits by trying to squeak out an extra $0.10 on a sell price.

PCU

Also triggering this morning was the $1.25 sell price on your PVX March 10 Calls (PVX CB).If you recall, last week I instructed you to place this $1.25 sell price and leave the order open, with the hopes of getting filled at the open of trading this week. As it turns out, these $1.25 sell prices did in fact trigger, locking a gain between 19% and 31% depending on your entry price.

Now I’d like to follow up on what I said earlier today about some interesting developments that are leading to new trading opportunities.

First up is Charles Schwab (SCHW – NASDAQ).

SCHW

According to my due-diligence, there is a high degree of liquidity still sitting on the sidelines, as retail investors wait to buy into the markets. But as the Dow and S&P continue to set new highs, I feel we’ll witness more and more retail buying interest, which should act as a bullish catalyst for established brokers like SCHW. As a longer-term play, lets’ get positioned to the upside in SCHW using the January 17.5 Calls.

PLAY: Buy the Charles Schwab January 17.5 Calls (SHQ AW) at or under $1.90, good for the day. Place a protective stop loss at $1.20.

Playing alongside the same thesis, we have NASDAQ Stock Market (NDAQ – NASDAQ).Although it’s been completely overshadowed by other names like the $500-a-share Chicago Mercantile Exchange (CME – NYSE) or the new $135-a-share NYMEX (NMX – NYSE) IPO, NDAQ should get a lift as more and more retail investors flock back into the tech-heavy NASDAQ. In fact, if we see heavy portfolio positioning for 2007, NDAQ could witness a very nice jump over the next few months.

NDAQ

Add into the equation the speculation of acquiring the London Stock Exchange (which would create the world’s largest equity market by listings, with more than 6,400 quoted companies and a total market capitalization of $11.3 trillion) and I think we should add NDAQ calls to our ledger.

PLAY: Buy the NDAQ January 40 Calls (NQD AH) at or under $1.60, good for the day. Place a protective stop loss at $0.85.

Also moving up at a strong clip is Goldman Sachs Group (GS – NYSE).If you recall, I predicted that GS would make an upside push to $200 a share before the calendar turns to 2007. As I write, GS has just hit a new 52-week high at $198.11, which means that my $200 prediction could easily come into play. Therefore, let’s make a speculative play and buy some upside GS calls.

GS

PLAY: Buy the GS December 200 Calls (GPY LT) at or under $5.20, good for the day. Place a protective stop loss at $3.20.

I also mentioned silicone breast maker Allergan (AGN – NYSE) this morning, after they received FDA approval over the weekend for silicone-gel breast implants for cosmetic purposes. But right now, I think the stock is popping too much for us to make a play, so let’s continue to monitor it for any opportunities going forward.

AGN

Looking at our SUN January 70 Calls (SUN AN), the continued weakness in the oil sector has stopped this position out. I maintain my position that SUN is the must under-valued oil refiner, as its stock performance has not nearly been as strong as Marathon Oil (MRO – NYSE) and others.

SUN

In fact, we may have a prime opportunity to use the recent oil weakness to add some longer-dated calls to our ledger at depressed levels. When the time is right, you’ll be the first to know. Until then…

Lock and load!

Sincerely,

Bryan Bottarelli

Bryan Bottarelli
Editor, Bottarelli Research

© 2012 CSR Group, LLC. All rights reserved. Published in USA.

Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.

Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.

CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.

Bottarelli Research alerts contain time-sensitive information, and are published and distributed to members with urgency. Because of this, not all published materials can be adequately proofread, and an occasional spelling or grammar error may exist.



Other Options Alerts From November 2006